Company intelligence
NodThera
Inflammation interrupted. Restoring balance to improve lives.
Biotechnology Research
Boston, US
28 employees
Founded 2016
1 public signals
About NodThera
NodThera is developing a new class of potent and highly selective NLRP3 inhibitors for the treatment of diseases driven by chronic inflammation. We’re building a dynamic team of people across our offices in Cambridge, UK and Boston, MA; all united by our shared ambition, enthusiasm, and creativity.
Verified activity
Signals from NodThera
1 published signal